Clinical Trials Evaluate New Treatment for Anal Cancer

Friday, January 20, 2017 - 11:01 in Health & Medicine

The addition of the drug cetuximab to a standard chemotherapy and radiation regimen reduced the incidence of disease persistence or recurrence in patients with anal cancer, but was also associated with significant adverse effects, according ... Read more

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net